158 related articles for article (PubMed ID: 18057552)
21. Antidiabetic activity of a xanthone compound, mangiferin.
Miura T; Ichiki H; Hashimoto I; Iwamoto N; Kato M; Kubo M; Ishihara E; Komatsu Y; Okada M; Ishida T; Tanigawa K
Phytomedicine; 2001 Mar; 8(2):85-7. PubMed ID: 11315760
[TBL] [Abstract][Full Text] [Related]
22. (-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus.
Freund P; Wolff HP; Kühnle HF
Metabolism; 1995 May; 44(5):570-6. PubMed ID: 7752903
[TBL] [Abstract][Full Text] [Related]
23. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
24. Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats.
Singh J; Kakkar P
Food Chem Toxicol; 2013 Dec; 62():722-31. PubMed ID: 24140466
[TBL] [Abstract][Full Text] [Related]
25. Rhizoma Anemarrhenae extract ameliorates hyperglycemia and insulin resistance via activation of AMP-activated protein kinase in diabetic rodents.
Han J; Yang N; Zhang F; Zhang C; Liang F; Xie W; Chen W
J Ethnopharmacol; 2015 Aug; 172():368-76. PubMed ID: 26162543
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity.
Kaneto H; Kajimoto Y; Miyagawa J; Matsuoka T; Fujitani Y; Umayahara Y; Hanafusa T; Matsuzawa Y; Yamasaki Y; Hori M
Diabetes; 1999 Dec; 48(12):2398-406. PubMed ID: 10580429
[TBL] [Abstract][Full Text] [Related]
27. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.
Stevenson RW; Hutson NJ; Krupp MN; Volkmann RA; Holland GF; Eggler JF; Clark DA; McPherson RK; Hall KL; Danbury BH
Diabetes; 1990 Oct; 39(10):1218-27. PubMed ID: 2210074
[TBL] [Abstract][Full Text] [Related]
28. Hypoglycemic, hypolipidemic and antioxidant effects of Sarcandra glabra polysaccharide in type 2 diabetic mice.
Liu W; Zheng Y; Zhang Z; Yao W; Gao X
Food Funct; 2014 Nov; 5(11):2850-60. PubMed ID: 25254968
[TBL] [Abstract][Full Text] [Related]
29. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y
J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032
[TBL] [Abstract][Full Text] [Related]
30. [Effects of Panax notoginseng saponins on anti-hyperglycemic, anti-obese and prevention from kidney pathological changes in KK-Ay mice].
Yang CY; Xie ZG; Cheng WB; Jiang X; Chen ZH
Zhong Yao Cai; 2009 Oct; 32(10):1571-6. PubMed ID: 20112724
[TBL] [Abstract][Full Text] [Related]
31. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice.
Miura T; Itoh C; Iwamoto N; Kato M; Kawai M; Park SR; Suzuki I
J Nutr Sci Vitaminol (Tokyo); 2001 Oct; 47(5):340-4. PubMed ID: 11814149
[TBL] [Abstract][Full Text] [Related]
32. Free fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo.
Oprescu AI; Bikopoulos G; Naassan A; Allister EM; Tang C; Park E; Uchino H; Lewis GF; Fantus IG; Rozakis-Adcock M; Wheeler MB; Giacca A
Diabetes; 2007 Dec; 56(12):2927-37. PubMed ID: 17717282
[TBL] [Abstract][Full Text] [Related]
33. Challenge of studies on the development of new Zn complexes (Zn(opt)₂) to treat diabetes mellitus.
Yoshikawa Y; Murayama A; Adachi Y; Sakurai H; Yasui H
Metallomics; 2011 Jul; 3(7):686-92. PubMed ID: 21584335
[TBL] [Abstract][Full Text] [Related]
34. N-Acetyl-l-Cysteine treatment efficiently prevented pre-diabetes and inflamed-dysmetabolic liver development in hypothalamic obese rats.
Villagarcía HG; Castro MC; Arbelaez LG; Schinella G; Massa ML; Spinedi E; Francini F
Life Sci; 2018 Apr; 199():88-95. PubMed ID: 29522769
[TBL] [Abstract][Full Text] [Related]
35. Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
Iwai M; Kanno H; Inaba S; Senba I; Sone H; Nakaoka H; Horiuchi M
Am J Hypertens; 2011 Feb; 24(2):169-74. PubMed ID: 20847723
[TBL] [Abstract][Full Text] [Related]
36. New antidiabetic compounds, mangiferin and its glucoside.
Ichiki H; Miura T; Kubo M; Ishihara E; Komatsu Y; Tanigawa K; Okada M
Biol Pharm Bull; 1998 Dec; 21(12):1389-90. PubMed ID: 9881663
[TBL] [Abstract][Full Text] [Related]
37. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
Saha TK; Yoshikawa Y; Sakurai H
ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
[TBL] [Abstract][Full Text] [Related]
38. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
Takino T; Yasui H; Yoshitake A; Hamajima Y; Matsushita R; Takada J; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):133-42. PubMed ID: 11293406
[TBL] [Abstract][Full Text] [Related]
39. Antidiabetic effect of Nitobegiku, the herb Tithonia diversifolia, in KK-Ay diabetic mice.
Miura T; Nosaka K; Ishii H; Ishida T
Biol Pharm Bull; 2005 Nov; 28(11):2152-4. PubMed ID: 16272709
[TBL] [Abstract][Full Text] [Related]
40. Antidiabetic effects of corosolic acid in KK-Ay diabetic mice.
Miura T; Ueda N; Yamada K; Fukushima M; Ishida T; Kaneko T; Matsuyama F; Seino Y
Biol Pharm Bull; 2006 Mar; 29(3):585-7. PubMed ID: 16508174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
